Clinical trial of L‐Carnitine and valproic acid in spinal muscular atrophy type I

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-4598|57|2|193-199

ISSN： 0148-639x

Source： MUSCLE AND NERVE, Vol.57, Iss.2, 2018-02, pp. : 193-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Training improves oxidative capacity, but not function, in spinal muscular atrophy type III

By  

MUSCLE AND NERVE, Vol. 52, Iss. 2, 2015-08 ,pp. : 240-244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Respiratory failure in infants due to spinal muscular atrophy with respiratory distress type 1

By Giannini Alberto   Pinto Anna   Rossetti Giordano   Prandi Edi   Tiziano Danilo   Brahe Christina   Nardocci Nardo  

Intensive Care Medicine, Vol. 32, Iss. 11, 2006-11 ,pp. : 1851-1855

Springer Publishing Company

Access to resources Recommend Favorite

Physical complaints in ageing persons with spinal muscular atrophy

By De Groot Imelda   De Witte Luc  

Journal of Rehabilitation Medicine, Vol. 37, Iss. 4, 2005-07 ,pp. : 258-262

Medical Journals Limited

Access to resources Recommend Favorite

Spinal muscular atrophy: Development and implementation of potential treatments

By  

ANNALS OF NEUROLOGY, Vol. 74, Iss. 3, 2013-09 ,pp. : 348-362

John Wiley & Sons Inc

Access to resources Recommend Favorite

FRACTURE RISK IN PATIENTS WITH MUSCULAR DYSTROPHY AND SPINAL MUSCULAR ATROPHY

By Vestergaard Peter   Glerup Henning   Steffensen Birgit F.   Rejnmark Lars   Rahbek Jes   Mosekilde Leif  

Journal of Rehabilitation Medicine, Vol. 33, Iss. 4, 2001-07 ,pp. : 150-155

Medical Journals Limited

Access to resources Recommend Favorite